Related Experiment Videos
Torsades de pointes and long QT syndromes
1Section of Cardiac Electrophysiology, St. Mary's Medical Center, Evansville, IN 47714, USA.
American Family Physician
|October 1, 1995
Summary
Torsades de pointes, a dangerous heart rhythm, is linked to QT interval prolongation. Recognizing and treating the underlying cause, not traditional drugs, is key for patient safety.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Torsades de pointes is a polymorphic ventricular tachycardia.
- It is typically associated with QT interval prolongation, which can be congenital or acquired.
- Acquired causes include electrolyte imbalances, starvation, and certain medications.
Purpose of the Study:
- To highlight the critical importance of accurate recognition of Torsades de pointes.
- To emphasize the risks associated with traditional antiarrhythmic drug treatment in this condition.
- To outline effective management strategies for Torsades de pointes.
Main Methods:
- Review of established medical literature on Torsades de pointes.
- Analysis of common etiologies and implicated medications.
- Evaluation of treatment outcomes for various therapeutic approaches.
Main Results:
- Drug effects are a significant cause of acquired QT prolongation and Torsades de pointes.
- Standard antiarrhythmic drugs can exacerbate Torsades de pointes.
- Withdrawal of offending agents and correction of underlying causes are primary treatments.
Conclusions:
- Prompt identification of Torsades de pointes is crucial to avoid harmful interventions.
- Management focuses on addressing the root cause of QT prolongation.
- Beta-blockers and implantable cardioverter-defibrillators have roles in specific patient populations.